Brian Conyer is cofounder and CEO of Giblib.
We’ve got the usual predictions, plus backstories on a trio of pharma marketing practices.
Cutting prescription drug prices has become one of the most popular campaign promises of our time.
What existing and future trends do marketers in the rare diseases area need to be mindful of to optimize their efforts?
Roy Scheider’s words to Robert Shaw on the deck of the fictitious vessel Orca apply to the real-life situation faced by health marketers. Here are five areas where “bigger boat” thinking applies.
Please login or register first to view this content.